Digital vascular biomarker platform for arterial health screening and remote cardiovascular monitoring. Enables point-of-care risk stratification, early disease detection, and progression tracking through non-invasive assessment of arterial stiffness and vascular health status.
Manufactured by
China
Cardiex is a digital health technology company developing and marketing noninvasive patient monitoring technologies for cardiovascular health assessment. The company's FDA-cleared and patented SphygmoCor vascular biosensing technology is deployed in over 4,500 installations worldwide at major medical and research institutions for clinical diagnosis and management of hypertension and cardiovascular diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
5 of 5 closest product alternatives
Siemens Healthineers · United States
Comprehensive testing system providing earlier and more holistic assessment of cardiometabolic health with integrated biomarker analysis for risk identification and management.
Shi Ji Yi kang (Tianjin) Medical Technology Development Co., Ltd. · China
Point-of-care testing platform for monitoring anticoagulant and antiplatelet drug therapy. Enables individualized drug management and assessment of medication efficacy. Supports compliance monitoring in cardiovascular and cerebrovascular disease management.
Chengdu Stork Healthcare Co.,Ltd. · China
Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.
Siemens Healthineers · United States
Integrated testing platform providing comprehensive evaluation of cardiometabolic health parameters for earlier risk detection. Supports longitudinal monitoring and holistic patient assessment.
EXOSYSTEMS Inc. · South Korea
A digital biomarker-based monitoring system designed for tracking disease progression and treatment response in musculoskeletal conditions. The platform enables objective, quantifiable follow-up assessments with reduced subjectivity and improved accessibility for patients with mobility limitations.
© 2026 Suplivia · Home · Browse Products